The high expression of GFPT2 is closely related to invasion, metastasis, drug sensitivity, and poor prognosis of a variety of tumors including lung cancer [124, 125], epithelial ovarian cancer [126–128], CRC [129], breast cancer [130, 131], GC [132] and leiomyosarcoma [133]. The gene discussed is GFPT2; the disease is colorectal carcinoma.